knowledge -WSS

knowledge

author：entertainment 2025-09-27 10:00:27 - browse：73615

Photo illustration of Covid 19 testing swabs on a blue background. — Timothy Stenzel led the FDA's diagnostics division during the Covid-19 pandemic, as the agency scrambled to push through and validate accurate Covid tests. Adobe

Timothy Stenzel, the federal regulator who led the Food and Drug Administration’s diagnostics division during the chaotic time of Covid-19 pandemic, has left the agency. The FDA confirmed Thursday that Stenzel, who led the FDA’s office of in vitro diagnostics, retired at the end of 2023.

During the early days of the pandemic, Stenzel was in the middle of a turf battle between the Centers for Disease Control and Prevention and the FDA over the regulation of Covid tests. At one point, the CDC made Stenzel wait at its facility overnight after he arrived for a meeting on Covid test development, Politico reported at the time.

It was a hectic time. Testmakers rapidly introduced new Covid-19 screening products with little data, as it was a brand new virus. The pandemic especially laid bare FDA’s inability to control lab-developed tests (LDTs). Many of the Covid-19 PCR tests fell in this category. Early on, using powers granted by the public health emergency, the FDA required labs to apply for emergency use authorization. But a STAT investigation found that the Department of Health and Human Services told the FDA to stop this measure, despite knowing that many of the tests may have been inaccurate.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Amylyx's ALS drug launch starts strong. It could be trouble for FDA

WSS

Why Talkspace is targeting Medicare, a tricky market

Naloxone nonprofit donates 200,000 doses after FDA approval

Naloxone nonprofit donates 200,000 doses after FDA approval

Lack of health data on LGBTQ+ people has serious consequences

How to use technology to prevent future drug shortages

The best solution to the drug shortages problem

Wikipedia

knowledge

explore

Novavax promises a turnaround & Lilly roils the obesity market

How to use technology to prevent future drug shortages

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Why Talkspace is targeting Medicare, a tricky market

Medical records are filled with copy

Ancient Greek ideas underpin modern concepts of pregnancy

Walensky prepares to leave CDC — and Congress — behind

The best solution to the drug shortages problem

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

hotspot

South Korea throws huge K

Wegovy’s successful heart trial raises vital question about weight loss

Fetal cell organoids grown from amniotic fluid, study finds

Naloxone nonprofit donates 200,000 doses after FDA approval

He's 19 months old and has one of the world’s rarest diseases

Wegovy’s successful heart trial raises vital question about weight loss

hotspot

entertainment

explore

hotspot